NEW YORK, Dec. 16 (GenomeWeb News) - Sequenom said today that it had penned agreements for its gene expression analysis technology with the Institute for Genomic Research in Rockville, Md., and the University of Michigan Medical Center.
TIGR is using the technology, which runs on Sequenom's MassArray Compact System, to study the way genetic polymorphisms functionally impact gene expression, the San Diego-based company said.
The University of Michigan Medical Center has purchased Sequenom's MassArray 7K system, which is designed to enable quantitative detection of low-copy-number genes. The Pediatrics and Human Genetics department is using this system, according to Sequenom.